Skip to content

Chocolate™ CB1812060120OTWRecalls & reported problems

Medtronic, Inc. · PTA CB1812060120 CHOCOLATE 018 V05 · Class 2

All models of Chocolate (17)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000500238), received between May 15, 2024 and Dec 10, 2025 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Deflation Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Deflation Problem1
  • Detachment of Device or Device Component1
  • Difficult to Remove1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 10, 2025Deflation Problem; Deflation Problem

    IT WAS REPORTED THAT DURING A PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY PROCEDURE TO TREAT A PERIPHERAL/ENDOVENOUS LESION WITH MODERATE CALCIFICATION IN THE MID SUPERFICIAL FEMORAL ARTERY, THE PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY CHOCOLATE 018 BALLOON EXHIBITED DEFLATION DIFFICULTIES. THE DEVICE WAS SLOW TO DEFLATE AT THE LESION SITE, AND DEFLATION ISSUES WERE NOTED DURING SUBSEQUENT INFLATION. DURING THE FOURTH INFLATION, THE NITINOL CONSTRAINING WIRE FAILED TO RETRACT INTO THE BALLOON. THE PROCEDURE WAS COMPLETED BY REPLACING THE DEVICE WITH A 6-80 CB. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23766954 ↗
  • InjuryMay 15, 2024Difficult to Remove; Detachment of Device or Device Component; Difficult to Remove; Detachment of Device or Device Component

    LIMITED INFORMATION REPORTED THAT DURING REMOVAL OF THE CHOCOLATE PTA BALLOON CATHETER AFTER AN ANGIOPLASTY PROCEDURE, THE NITINOL CONTAINING CAGE WAS STRIPPED AND RETAINED WITHIN THE PATIENT WHEN THE CATHETER WAS ENTANGLED WITH THE PREVIOUS STENT¿S STRUTS. THERE WERE NO ATTEMPTS TO REMOVE THE CAGE, THE PHYSICIAN BALLOONED THE CAGE AGAINST THE VESSEL WALL THEN PLACED AN EVERFLEX STENT. THE PREVIOUSLY DEPLOYED STENT IS NOT KNOWN. THERE WAS NO DEFORMATION NOTED TO THE DEPLOYED STENT. THERE WAS NO VESSEL DAMAGE. NO PATIENT INJURY REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19320666 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page